Bond, value

No definition available.

Name:	myl_BondValue
Namespace Prefix:	myl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of drugs

+ References

No definition available.

+ Details

Name:	myl_NumberOfDrugs
Namespace Prefix:	myl_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

The voluntary remittitur from plaintiffs

+ References

No definition available.

+ Details

Name:	myl_VoluntaryRemittiturFromPlaintiffs
Namespace Prefix:	myl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of loss contingency liability.

+ References

+ Details

Name:	us-gaap_LossContingencyAccrualAtCarryingValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of damages awarded to the plaintiff in the legal matter.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

+ Details

Name:	us-gaap_LossContingencyDamagesAwardedValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The value (monetary amount) of the award the plaintiff seeks in the legal matter.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

+ Details

Name:	us-gaap_LossContingencyDamagesSoughtValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of plaintiffs that have filed claims pertaining to a loss contingency.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingencyNumberOfPlaintiffs
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_LitigationCaseAxis=myl_LorazepamAndClorazepateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=myl_FoundInViolationOfAntitrustLawsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=myl_HealthInsurersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=myl_JudgmentReflectsTreblingOfCompensatoryDamagesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=myl_OriginalVerdictMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=myl_OriginalVerdictPlusPunitiveDamagesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=myl_SelfFundedCustomersVoluntarilyDismissedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=myl_SelfFundedCustomersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_SuretyBondMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Contingencies (Lorazepam and Clorazepate) (Narrative) (Details) - Lorazepam and Clorazepate $ in Millions					3 Months Ended
	Jan. 14, 2013 USD ($) plantiffs	May 30, 2012 USD ($)	Feb. 06, 2008 USD ($) plantiffs	Jun. 01, 2005 USD ($) drugs Insurer	Jun. 30, 2016
Loss Contingencies [Line Items]
Loss contingency accrual				$ 12.0
Judgment issued			$ 69.0
Damages sought			$ 8.0
Voluntary remittitur from plaintiffs	$ 8.1
Found in violation of antitrust laws
Loss Contingencies [Line Items]
Number of drugs \| drugs				2
Health insurers
Loss Contingencies [Line Items]
Number of plaintiffs				4	2
Judgment reflects trebling of compensatory damages
Loss Contingencies [Line Items]
Number of plaintiffs \| plantiffs			3
Original verdict
Loss Contingencies [Line Items]
Judgment issued			$ 11.0
Original verdict plus punitive damages
Loss Contingencies [Line Items]
Judgment issued			58.0
Self-funded customers voluntarily dismissed
Loss Contingencies [Line Items]
Number of plaintiffs \| plantiffs	775
Self-funded customers
Loss Contingencies [Line Items]
Number of plaintiffs \| plantiffs	1,387
Surety bond
Loss Contingencies [Line Items]
Bond		$ 66.6	$ 74.5